Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

397 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Preinfection laboratory parameters may predict COVID-19 severity in tumor patients.
Kiani A, Roesch R, Wendtner CM, Kullmann F, Kubin T, Südhoff T, Augustin M, Schaich M, Müller-Naendrup C, Illerhaus G, Hartmann F, Hebart H, Seggewiss-Bernhardt R, Bentz M, Späth-Schwalbe E, Reimer P, Kaiser U, Kapp M, Graeven U, Chemnitz JM, Baesecke J, Lambertz H, Naumann R. Kiani A, et al. Among authors: kapp m. Cancer Med. 2021 Jul;10(13):4424-4436. doi: 10.1002/cam4.4023. Epub 2021 Jun 13. Cancer Med. 2021. PMID: 34121360 Free PMC article.
Dendritic cell vaccination in allogeneic stem cell recipients: induction of human cytomegalovirus (HCMV)-specific cytotoxic T lymphocyte responses even in patients receiving a transplant from an HCMV-seronegative donor.
Grigoleit GU, Kapp M, Hebart H, Fick K, Beck R, Jahn G, Einsele H. Grigoleit GU, et al. Among authors: kapp m. J Infect Dis. 2007 Sep 1;196(5):699-704. doi: 10.1086/520538. Epub 2007 Jul 18. J Infect Dis. 2007. PMID: 17674311 Clinical Trial.
MET Amplification in Non-Small Cell Lung Cancer (NSCLC)-A Consecutive Evaluation Using Next-Generation Sequencing (NGS) in a Real-World Setting.
Schubart C, Stöhr R, Tögel L, Fuchs F, Sirbu H, Seitz G, Seggewiss-Bernhardt R, Leistner R, Sterlacci W, Vieth M, Seidl C, Mugler M, Kapp M, Hohenforst-Schmidt W, Hartmann A, Haller F, Erber R. Schubart C, et al. Among authors: kapp m. Cancers (Basel). 2021 Oct 7;13(19):5023. doi: 10.3390/cancers13195023. Cancers (Basel). 2021. PMID: 34638507 Free PMC article.
Cellular therapy to control tumor progression.
Kapp M, Rasche L, Einsele H, Grigoleit GU. Kapp M, et al. Curr Opin Hematol. 2009 Nov;16(6):437-43. doi: 10.1097/MOH.0b013e32832f57d4. Curr Opin Hematol. 2009. PMID: 19587587 Review.
CMV-specific T cell therapy.
Einsele H, Kapp M, Grigoleit GU. Einsele H, et al. Among authors: kapp m. Blood Cells Mol Dis. 2008 Jan-Feb;40(1):71-5. doi: 10.1016/j.bcmd.2007.07.002. Epub 2007 Sep 11. Blood Cells Mol Dis. 2008. PMID: 17851094 Review.
T-cell therapy for cytomegalovirus infection.
Mui TS, Kapp M, Einsele H, Grigoleit GU. Mui TS, et al. Among authors: kapp m. Curr Opin Organ Transplant. 2010 Dec;15(6):744-50. doi: 10.1097/MOT.0b013e32834016b9. Curr Opin Organ Transplant. 2010. PMID: 20930639 Review.
Adoptive immunotherapy of HCMV infection.
Kapp M, Tan SM, Einsele H, Grigoleit G. Kapp M, et al. Cytotherapy. 2007;9(8):699-711. doi: 10.1080/14653240701656046. Epub 2007 Oct 4. Cytotherapy. 2007. PMID: 17917875 Review.
397 results